Karishma Dhuri

808 total citations · 1 hit paper
10 papers, 592 citations indexed

About

Karishma Dhuri is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Karishma Dhuri has authored 10 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Karishma Dhuri's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and MicroRNA in disease regulation (4 papers). Karishma Dhuri is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers) and MicroRNA in disease regulation (4 papers). Karishma Dhuri collaborates with scholars based in United States and India. Karishma Dhuri's co-authors include Raman Bahal, Anisha Gupta, Ajit Vikram, Hà Phạm, Elias Quijano, Aniket Wahane, Rajkumar Verma, Frank J. Slack, Ravinder Reddy Gaddam and Kaikobad Irani and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Karishma Dhuri

10 papers receiving 577 citations

Hit Papers

Antisense Oligonucleotides: An Emerging Area in Drug Disc... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karishma Dhuri United States 6 489 136 74 39 38 10 592
Katherine L. West United Kingdom 15 849 1.7× 128 0.9× 69 0.9× 33 0.8× 85 2.2× 24 1.0k
Diala El Khoury France 8 395 0.8× 77 0.6× 19 0.3× 56 1.4× 52 1.4× 10 540
Yanli Ren China 16 361 0.7× 243 1.8× 29 0.4× 36 0.9× 51 1.3× 34 606
Luciano H. Apponi United States 18 979 2.0× 63 0.5× 61 0.8× 11 0.3× 47 1.2× 23 1.1k
Ajit Tiwari United States 14 404 0.8× 45 0.3× 62 0.8× 14 0.4× 46 1.2× 23 622
Sónia Duarte Portugal 11 324 0.7× 49 0.4× 136 1.8× 37 0.9× 51 1.3× 15 472
Fengbao Luo China 9 294 0.6× 47 0.3× 34 0.5× 16 0.4× 57 1.5× 13 482
Marina Manuvakhova United States 9 380 0.8× 25 0.2× 84 1.1× 20 0.5× 20 0.5× 10 495
Sébastien Mongrain Canada 6 228 0.5× 66 0.5× 78 1.1× 17 0.4× 39 1.0× 6 407
Alexander Kvist Sweden 10 502 1.0× 39 0.3× 110 1.5× 65 1.7× 59 1.6× 15 741

Countries citing papers authored by Karishma Dhuri

Since Specialization
Citations

This map shows the geographic impact of Karishma Dhuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karishma Dhuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karishma Dhuri more than expected).

Fields of papers citing papers by Karishma Dhuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karishma Dhuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karishma Dhuri. The network helps show where Karishma Dhuri may publish in the future.

Co-authorship network of co-authors of Karishma Dhuri

This figure shows the co-authorship network connecting the top 25 collaborators of Karishma Dhuri. A scholar is included among the top collaborators of Karishma Dhuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karishma Dhuri. Karishma Dhuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dhuri, Karishma, et al.. (2024). Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery. Molecular Therapy — Nucleic Acids. 35(4). 102355–102355. 2 indexed citations
2.
Dhuri, Karishma, Bodhisattwa Chaudhuri, Frank J. Slack, et al.. (2023). Head-to-head comparison of in vitro and in vivo efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids. Cell Reports Physical Science. 4(10). 101584–101584. 4 indexed citations
3.
Dhuri, Karishma, Jason Shi, Eleni Anastasiadou, et al.. (2022). Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. Pharmaceutical Research. 39(11). 2709–2720. 8 indexed citations
4.
Gaddam, Ravinder Reddy, Karishma Dhuri, Young‐Rae Kim, et al.. (2022). γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet. Journal of Medicinal Chemistry. 65(4). 3332–3342. 11 indexed citations
5.
Dhuri, Karishma, et al.. (2022). Serine-γPNA, Invader probes, and chimeras thereof: three probe chemistries that enable sequence-unrestricted recognition of double-stranded DNA. Organic & Biomolecular Chemistry. 20(44). 8714–8724. 3 indexed citations
6.
Dhuri, Karishma, et al.. (2021). Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy. Cells. 10(5). 1011–1011. 37 indexed citations
7.
Gaddam, Ravinder Reddy, Young‐Rae Kim, Mohanad Gabani, et al.. (2020). Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice. Scientific Reports. 10(1). 10065–10065. 12 indexed citations
8.
Dhuri, Karishma, Elias Quijano, Hà Phạm, et al.. (2020). Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. Journal of Clinical Medicine. 9(6). 2004–2004. 368 indexed citations breakdown →
9.
Wahane, Aniket, et al.. (2020). Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy. Molecules. 25(12). 2866–2866. 145 indexed citations
10.
Kp, Skandhan, et al.. (2013). Pheromones in Human Urine: A Study. 3(2). 35–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026